RAPS

FDA approves aducanumab for use in Alzheimer’s disease

The U.S. Food and Drug Administration (FDA) on Monday announced the approval of Biogen’s human monoclonal antibody Aduhelm (aducanumab) for use in patients with Alzheimer’s disease under the agency’s ...
WRBL

FDA approves first Alzheimer’s drug in nearly 20 years despite controversy

WASHINGTON (AP) — Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated ...
RAPS

FDA defends Aduhelm's accelerated approval, while others call for reform

Three papers published as Viewpoints in JAMA Internal Medicine this week highlight the rationale provided by the US Food and Drug Administration (FDA) on the agency’s approval of aducanumab (Aduhelm; ...
ScienceAlert

Rare Autopsy Finds Alzheimer's Drugs Only Work in Some Parts of The Brain

We had so much hope for new generations of Alzheimer's drugs, but unfortunately, many just aren't performing like we thought ...
MedscapeOpinion

Is Alzheimer’s Research Focusing on the Wrong Target?

Antiamyloid drugs clear amyloid plaques and modestly slow cognitive decline in patients with Alzheimer’s disease, but whether ...